Our experienced attorneys will review the details of your case, discuss the severity of your gastrointestinal complications, and let you know if you can file a legal claim against Eli Lilly and Company for compensation
Beyond weight reduction, the highest retatrutide dose produced clinically meaningful improvements in several cardiometabolic risk markers, including average reductions of 37.0% in triglycerides, 16.5% in non-HDL cholesterol, 9.3 mmHg in systolic blood pressure, 19.0 cm in waist circumference, and 51.2% in high-sensitivity C-reactive protein (hsCRP), a marker of systemic inflammation
It is important to note that Phase 2 data, whilst promising, do not yet constitute the full evidence base required for regulatory approval
When levels run low, skin can look duller and more uneven
Recent progress in mucosal vaccine development: potential and limitations